Novo Nordisk Expands Wegovy's Global Reach Beyond U.S. Market
Novo Nordisk plans to launch its weight-loss drug, Wegovy, outside the United States later this year, aiming for global expansion in markets like the UK and Germany. The company sees significant potential beyond the current focus on the lucrative U.S. market.
